{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T18:31:47Z","timestamp":1794508307632,"version":"4.9.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Genet"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1038\/s41588-026-02613-y","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T09:02:16Z","timestamp":1779699736000},"page":"1268-1279","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Exome-wide association study of blood lipids in 1,158,017 individuals from diverse populations"],"prefix":"10.1038","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9286-0360","authenticated-orcid":false,"given":"Satoshi","family":"Koyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4810-3474","authenticated-orcid":false,"given":"Zhi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Hoan","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1605-9782","authenticated-orcid":false,"given":"Sean J.","family":"Jurgens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret Sunitha","family":"Selvaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4636-5780","authenticated-orcid":false,"given":"Derek","family":"Klarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9672-2491","authenticated-orcid":false,"given":"Jennifer E.","family":"Huffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6592-1172","authenticated-orcid":false,"given":"Shoa L.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4499-4820","authenticated-orcid":false,"given":"Selena K.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael N.","family":"Trinh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshaya","family":"Ravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3045-6530","authenticated-orcid":false,"given":"Jacqueline S.","family":"Dron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Spinks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Surakka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4699-6779","authenticated-orcid":false,"given":"Aarushi","family":"Bhatnagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Lannery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Whitney","family":"Hornsby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8009-1632","authenticated-orcid":false,"given":"Scott M.","family":"Damrauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6811-9364","authenticated-orcid":false,"given":"Kyong-Mi","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0108-2127","authenticated-orcid":false,"given":"Julie A.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2349-0009","authenticated-orcid":false,"given":"Themistocles L.","family":"Assimes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7274-9318","authenticated-orcid":false,"given":"Philip S.","family":"Tsao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9245-9876","authenticated-orcid":false,"given":"Daniel J.","family":"Rader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5355-8636","authenticated-orcid":false,"given":"Gina M.","family":"Peloso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2067-0533","authenticated-orcid":false,"given":"Patrick T.","family":"Ellinor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2838-1824","authenticated-orcid":false,"given":"Yan V.","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5653-7056","authenticated-orcid":false,"given":"Peter W. F.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"VA Million Veteran Program","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8402-7435","authenticated-orcid":false,"given":"Pradeep","family":"Natarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"key":"2613_CR1","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1093\/eurheartj\/ehv157","volume":"36","author":"A Wiegman","year":"2015","unstructured":"Wiegman, A. et al. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment. Eur. Heart J. 36, 2425\u20132437 (2015).","journal-title":"Eur. Heart J."},{"key":"2613_CR2","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1161\/CIR.0000000000000297","volume":"132","author":"SS Gidding","year":"2015","unstructured":"Gidding, S. S. et al. The agenda for familial hypercholesterolemia: a scientific statement from the American Heart Association. Circulation 132, 2167\u20132192 (2015).","journal-title":"Circulation"},{"key":"2613_CR3","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.a2423","volume":"337","author":"J Versmissen","year":"2008","unstructured":"Versmissen, J. et al. Efficacy of statins in familial hypercholesterolaemia: a long term cohort study. BMJ 337, a2423 (2008).","journal-title":"BMJ"},{"key":"2613_CR4","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1093\/eurheartj\/ehn422","volume":"29","author":"A Neil","year":"2008","unstructured":"Neil, A. et al. Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study. Eur. Heart J. 29, 2625\u20132633 (2008).","journal-title":"Eur. Heart J."},{"key":"2613_CR5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.atherosclerosis.2009.09.014","volume":"209","author":"AH Pijlman","year":"2010","unstructured":"Pijlman, A. H. et al. Evaluation of cholesterol lowering treatment of patients with familial hypercholesterolemia: a large cross-sectional study in The Netherlands. Atherosclerosis 209, 189\u2013194 (2010).","journal-title":"Atherosclerosis"},{"key":"2613_CR6","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","volume":"34","author":"BG Nordestgaard","year":"2013","unstructured":"Nordestgaard, B. G. et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur. Heart J. 34, 3478\u20133490 (2013).","journal-title":"Eur. Heart J."},{"key":"2613_CR7","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jacc.2018.05.044","volume":"72","author":"AC Sturm","year":"2018","unstructured":"Sturm, A. C. et al. Clinical genetic testing for familial hypercholesterolemia: JACC Scientific Expert Panel. J. Am. Coll. Cardiol. 72, 662\u2013680 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"2613_CR8","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1093\/eurheartj\/ehw028","volume":"37","author":"M Benn","year":"2016","unstructured":"Benn, M., Watts, G. F., Tybjaerg-Hansen, A. & Nordestgaard, B. G. Mutations causative of familial hypercholesterolaemia: screening of 98,098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217. Eur. Heart J. 37, 1384\u20131394 (2016).","journal-title":"Eur. Heart J."},{"key":"2613_CR9","doi-asserted-by":"crossref","first-page":"364ra151","DOI":"10.1126\/scitranslmed.aag2367","volume":"8","author":"P Natarajan","year":"2016","unstructured":"Natarajan, P. et al. Aggregate penetrance of genomic variants for actionable disorders in European and African Americans. Sci. Transl. Med. 8, 364ra151\u2013364ra361 (2016).","journal-title":"Sci. Transl. Med."},{"key":"2613_CR10","volume":"11","author":"YV Sun","year":"2018","unstructured":"Sun, Y. V. et al. Effects of genetic variants associated with familial hypercholesterolemia on low-density lipoprotein-cholesterol levels and cardiovascular outcomes in the Million Veteran Program. Circ. Genom. Precis. Med. 11, e002192 (2018).","journal-title":"Circ. Genom. Precis. Med."},{"key":"2613_CR11","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1001\/jama.2021.23686","volume":"327","author":"IS Forrest","year":"2022","unstructured":"Forrest, I. S. et al. Population-based penetrance of deleterious clinical variants. JAMA 327, 350\u2013359 (2022).","journal-title":"JAMA"},{"key":"2613_CR12","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.121.003501","volume":"15","author":"SL Clarke","year":"2022","unstructured":"Clarke, S. L. et al. Coronary artery disease risk of familial hypercholesterolemia genetic variants independent of clinically observed longitudinal cholesterol exposure. Circ. Genom. Precis. Med. 15, e003501 (2022).","journal-title":"Circ. Genom. Precis. Med."},{"key":"2613_CR13","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf6814","volume":"354","author":"FE Dewey","year":"2016","unstructured":"Dewey, F. E. et al. Distribution and clinical impact of functional variants in 50,726 whole-exome sequences from the DiscovEHR study. Science 354, aaf6814 (2016).","journal-title":"Science"},{"key":"2613_CR14","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/gim.2013.73","volume":"15","author":"RC Green","year":"2013","unstructured":"Green, R. C. et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet. Med. 15, 565\u2013574 (2013).","journal-title":"Genet. Med."},{"key":"2613_CR15","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405\u2013424 (2015).","journal-title":"Genet. Med."},{"key":"2613_CR16","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/j.ajhg.2021.10.005","volume":"108","author":"CL Blout Zawatsky","year":"2021","unstructured":"Blout Zawatsky, C. L. et al. Returning actionable genomic results in a research biobank: analytic validity, clinical implementation, and resource utilization. Am. J. Hum. Genet. 108, 2224\u20132237 (2021).","journal-title":"Am. J. Hum. Genet."},{"key":"2613_CR17","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12521","volume":"7","author":"MD Kessler","year":"2016","unstructured":"Kessler, M. D. et al. Challenges and disparities in the application of personalized genomic medicine to populations with African ancestry. Nat. Commun. 7, 12521 (2016).","journal-title":"Nat. Commun."},{"key":"2613_CR18","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMsa1507092","volume":"375","author":"AK Manrai","year":"2016","unstructured":"Manrai, A. K. et al. Genetic misdiagnoses and the potential for health disparities. N. Engl. J. Med. 375, 655\u2013665 (2016).","journal-title":"N. Engl. J. Med."},{"key":"2613_CR19","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ajhg.2020.03.004","volume":"106","author":"H Hunter-Zinck","year":"2020","unstructured":"Hunter-Zinck, H. et al. Genotyping array design and data quality control in the Million Veteran Program. Am. J. Hum. Genet. 106, 535\u2013548 (2020).","journal-title":"Am. J. Hum. Genet."},{"key":"2613_CR20","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft, C. et al. The UK Biobank resource with deep phenotyping and genomic data. Nature 562, 203\u2013209 (2018).","journal-title":"Nature"},{"key":"2613_CR21","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41586-021-03205-y","volume":"590","author":"D Taliun","year":"2021","unstructured":"Taliun, D. et al. Sequencing of 53,831 diverse genomes from the NHLBI TOPMed program. Nature 590, 290\u2013299 (2021).","journal-title":"Nature"},{"key":"2613_CR22","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/s41586-021-04103-z","volume":"599","author":"JD Backman","year":"2021","unstructured":"Backman, J. D. et al. Exome sequencing and analysis of 454,787 UK Biobank participants. Nature 599, 628\u2013634 (2021).","journal-title":"Nature"},{"key":"2613_CR23","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/s41586-023-06957-x","volume":"627","author":"AG Bick","year":"2024","unstructured":"Bick, A. G. et al. Genomic data in the All of Us Research Program. Nature 627, 340\u2013346 (2024).","journal-title":"Nature"},{"key":"2613_CR24","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cell.2018.12.015","volume":"176","author":"K Jaganathan","year":"2019","unstructured":"Jaganathan, K. et al. Predicting splicing from primary sequence with deep learning. Cell 176, 535\u2013548 (2019).","journal-title":"Cell"},{"key":"2613_CR25","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1038\/ng.3978","volume":"49","author":"X Lu","year":"2017","unstructured":"Lu, X. et al. Exome chip meta-analysis identifies novel loci and East Asian-specific coding variants that contribute to lipid levels and coronary artery disease. Nat. Genet. 49, 1722\u20131730 (2017).","journal-title":"Nat. Genet."},{"key":"2613_CR26","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski, K. J. et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581, 434\u2013443 (2020).","journal-title":"Nature"},{"key":"2613_CR27","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren, W. et al. The Ensembl Variant Effect Predictor. Genome Biol. 17, 122 (2016).","journal-title":"Genome Biol."},{"key":"2613_CR28","volume":"12","author":"X Liu","year":"2020","unstructured":"Liu, X., Li, C., Mou, C., Dong, Y. & Tu, Y. dbNSFP v4: a comprehensive database of transcript-specific functional predictions and annotations for human nonsynonymous and splice-site SNVs. Genome Med. 12, 103 (2020).","journal-title":"Genome Med."},{"key":"2613_CR29","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.ajhg.2023.08.005","volume":"110","author":"M Singer-Berk","year":"2023","unstructured":"Singer-Berk, M. et al. Advanced variant classification framework reduces the false positive rate of predicted loss-of-function variants in population sequencing data. Am. J. Hum. Genet. 110, 1496\u20131508 (2023).","journal-title":"Am. J. Hum. Genet."},{"key":"2613_CR30","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1161\/CIRCGENETICS.115.001129","volume":"8","author":"PN Hopkins","year":"2015","unstructured":"Hopkins, P. N. et al. Characterization of autosomal dominant hypercholesterolemia caused by PCSK9 gain of function mutations and its specific treatment with alirocumab, a PCSK9 monoclonal antibody. Circ. Cardiovasc. Genet. 8, 823\u2013831 (2015).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"2613_CR31","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41586-023-06045-0","volume":"625","author":"S Chen","year":"2024","unstructured":"Chen, S. et al. A genomic mutational constraint map using variation in 76,156 human genomes. Nature 625, 92\u2013100 (2024).","journal-title":"Nature"},{"key":"2613_CR32","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.aaz1776","volume":"369","author":"F Aguet","year":"2020","unstructured":"Aguet, F. et al. The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science 369, 1318\u20131330 (2020).","journal-title":"Science"},{"key":"2613_CR33","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1172\/JCI23858","volume":"115","author":"C Assanasen","year":"2005","unstructured":"Assanasen, C. et al. Cholesterol binding, efflux, and a PDZ-interacting domain of scavenger receptor\u2013BI mediate HDL-initiated signaling. J. Clin. Invest. 115, 969\u2013977 (2005).","journal-title":"J. Clin. Invest."},{"key":"2613_CR34","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cell.2005.12.022","volume":"124","author":"JL Goldstein","year":"2006","unstructured":"Goldstein, J. L., Debose-Boyd, R. A. & Brown, M. S. Protein sensors for membrane sterols. Cell 124, 35\u201346 (2006).","journal-title":"Cell"},{"key":"2613_CR35","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1093\/bioinformatics\/btv402","volume":"31","author":"MJ Machiela","year":"2015","unstructured":"Machiela, M. J. & Chanock, S. J. LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants. Bioinformatics 31, 3555\u20133557 (2015).","journal-title":"Bioinformatics"},{"key":"2613_CR36","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","volume":"53","author":"U V\u00f5sa","year":"2021","unstructured":"V\u00f5sa, U. et al. Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. Nat. Genet. 53, 1300\u20131310 (2021).","journal-title":"Nat. Genet."},{"key":"2613_CR37","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nature09266","volume":"466","author":"K Musunuru","year":"2010","unstructured":"Musunuru, K. et al. From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus. Nature 466, 714\u2013719 (2010).","journal-title":"Nature"},{"key":"2613_CR38","volume":"35","author":"J Tan","year":"2021","unstructured":"Tan, J. et al. CELSR2 deficiency suppresses lipid accumulation in hepatocyte by impairing the UPR and elevating ROS level. FASEB J. 35, e21908 (2021).","journal-title":"FASEB J."},{"key":"2613_CR39","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41586-021-04064-3","volume":"600","author":"SE Graham","year":"2021","unstructured":"Graham, S. E. et al. The power of genetic diversity in genome-wide association studies of lipids. Nature 600, 675\u2013679 (2021).","journal-title":"Nature"},{"key":"2613_CR40","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-022-02837-1","volume":"23","author":"S Kanoni","year":"2022","unstructured":"Kanoni, S. et al. Implicating genes, pleiotropy, and sexual dimorphism at blood lipid loci through multi-ancestry meta-analysis. Genome Biol. 23, 268 (2022).","journal-title":"Genome Biol."},{"key":"2613_CR41","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1021\/bi7016359","volume":"47","author":"D Fan","year":"2008","unstructured":"Fan, D. et al. Self-association of human PCSK9 correlates with its LDLR-degrading activity. Biochemistry 47, 1631\u20131639 (2008).","journal-title":"Biochemistry"},{"key":"2613_CR42","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.jacc.2020.01.033","volume":"75","author":"SA Burnap","year":"2020","unstructured":"Burnap, S. A. et al. High-density lipoproteins are the main carriers of PCSK9 in the circulation. J. Am. Coll. Cardiol. 75, 1495\u20131497 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"key":"2613_CR43","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1161\/CIRCRESAHA.121.319272","volume":"129","author":"SA Burnap","year":"2021","unstructured":"Burnap, S. A. et al. PCSK9 activity is potentiated through HDL binding. Circ. Res. 129, 1039\u20131053 (2021).","journal-title":"Circ. Res."},{"key":"2613_CR44","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1056\/NEJMoa1501031","volume":"372","author":"JG Robinson","year":"2015","unstructured":"Robinson, J. G. et al. Efficacy and safety of alirocumab in reducing lipids and cardiovascular events. N. Engl. J. Med. 372, 1489\u20131499 (2015).","journal-title":"N. Engl. J. Med."},{"key":"2613_CR45","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2020.106804","volume":"135","author":"C Ingueneau","year":"2020","unstructured":"Ingueneau, C. et al. Treatment with PCSK9 inhibitors induces a more anti-atherogenic HDL lipid profile in patients at high cardiovascular risk. Vascul. Pharmacol. 135, 106804 (2020).","journal-title":"Vascul. Pharmacol."},{"key":"2613_CR46","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/j.celrep.2018.04.055","volume":"23","author":"W Xia","year":"2018","unstructured":"Xia, W. et al. Loss of ABHD15 impairs the anti-lipolytic action of insulin by altering PDE3B stability and contributes to insulin resistance. Cell Rep. 23, 1948\u20131961 (2018).","journal-title":"Cell Rep."},{"key":"2613_CR47","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1161\/01.RES.0000018002.43041.08","volume":"90","author":"H Al-Kateb","year":"2002","unstructured":"Al-Kateb, H. et al. Mutation in the ARH gene and a chromosome 13q locus influence cholesterol levels in a new form of digenic-recessive familial hypercholesterolemia. Circ. Res. 90, 951\u2013958 (2002).","journal-title":"Circ. Res."},{"key":"2613_CR48","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1126\/science.1060458","volume":"292","author":"CK Garcia","year":"2001","unstructured":"Garcia, C. K. et al. Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein. Science 292, 1394\u20131398 (2001).","journal-title":"Science"},{"key":"2613_CR49","doi-asserted-by":"crossref","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","volume":"46","author":"MJ Landrum","year":"2018","unstructured":"Landrum, M. J. et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 46, D1062\u2013D1067 (2018).","journal-title":"Nucleic Acids Res."},{"key":"2613_CR50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004331","volume":"10","author":"Y Takeda","year":"2014","unstructured":"Takeda, Y. et al. Retinoic acid-related orphan receptor \u03b3 (ROR\u03b3): a novel participant in the diurnal regulation of hepatic gluconeogenesis and insulin sensitivity. PLoS Genet. 10, e1004331 (2014).","journal-title":"PLoS Genet."},{"key":"2613_CR51","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.molmet.2016.07.001","volume":"5","author":"C Billon","year":"2016","unstructured":"Billon, C., Sitaula, S. & Burris, T. P. Inhibition of ROR\u03b1\/\u03b3 suppresses atherosclerosis via inhibition of both cholesterol absorption and inflammation. Mol. Metab. 5, 997\u20131005 (2016).","journal-title":"Mol. Metab."},{"key":"2613_CR52","volume":"10","author":"D Cai","year":"2019","unstructured":"Cai, D. et al. ROR\u03b3 is a targetable master regulator of cholesterol biosynthesis in a cancer subtype. Nat. Commun. 10, 4621 (2019).","journal-title":"Nat. Commun."},{"key":"2613_CR53","volume":"196","author":"H Zou","year":"2022","unstructured":"Zou, H., Yang, N., Zhang, X. & Chen, H.-W. ROR\u03b3 is a context-specific master regulator of cholesterol biosynthesis and an emerging therapeutic target in cancer and autoimmune diseases. Biochem. Pharmacol. 196, 114725 (2022).","journal-title":"Biochem. Pharmacol."},{"key":"2613_CR54","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1038\/s41588-024-01894-5","volume":"56","author":"SJ Jurgens","year":"2024","unstructured":"Jurgens, S. J. et al. Rare coding variant analysis for human diseases across biobanks and ancestries. Nat. Genet. 56, 1811\u20131820 (2024).","journal-title":"Nat. Genet."},{"key":"2613_CR55","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1038\/s41588-024-01913-5","volume":"56","author":"S Koyama","year":"2024","unstructured":"Koyama, S. et al. Population-specific putative causal variants shape quantitative traits. Nat. Genet. 56, 2027\u20132035 (2024).","journal-title":"Nat. Genet."},{"key":"2613_CR56","doi-asserted-by":"crossref","first-page":"7689","DOI":"10.1073\/pnas.1707741114","volume":"114","author":"K Ito","year":"2017","unstructured":"Ito, K. et al. Identification of pathogenic gene mutations in LMNA and MYBPC3 that alter RNA splicing. Proc. Natl Acad. Sci. USA 114, 7689\u20137694 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2613_CR57","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41586-022-05420-7","volume":"613","author":"HO Heyne","year":"2023","unstructured":"Heyne, H. O. et al. Mono- and biallelic variant effects on disease at biobank scale. Nature 613, 519\u2013525 (2023).","journal-title":"Nature"},{"key":"2613_CR58","volume":"13","author":"JL Halford","year":"2022","unstructured":"Halford, J. L. et al. Endophenotype effect sizes support variant pathogenicity in monogenic disease susceptibility genes. Nat. Commun. 13, 5106 (2022).","journal-title":"Nat. Commun."},{"key":"2613_CR59","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-024-07556-0","volume":"631","author":"KY Sun","year":"2024","unstructured":"Sun, K. Y. et al. A deep catalogue of protein-coding variation in 983,578 individuals. Nature 631, 583\u2013592 (2024).","journal-title":"Nature"},{"key":"2613_CR60","doi-asserted-by":"publisher","unstructured":"Koyama, S. et al. Genetics and context for precision health in Greater Boston. Nat. Commun. https:\/\/doi.org\/10.1038\/s41467-025-66598-8 (2023).","DOI":"10.1038\/s41467-025-66598-8"},{"key":"2613_CR61","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-025-03698-0","volume":"26","author":"MS Selvaraj","year":"2025","unstructured":"Selvaraj, M. S. et al. Whole genome sequence analysis of low-density lipoprotein cholesterol across 246K individuals. Genome Biol. 26, 273 (2025).","journal-title":"Genome Biol."},{"key":"2613_CR62","doi-asserted-by":"crossref","DOI":"10.1126\/science.adj1182","volume":"385","author":"A Verma","year":"2024","unstructured":"Verma, A. et al. Diversity and scale: genetic architecture of 2,068 traits in the VA Million Veteran Program. Science 385, eadj1182 (2024).","journal-title":"Science"},{"key":"2613_CR63","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1038\/s41588-018-0222-9","volume":"50","author":"D Klarin","year":"2018","unstructured":"Klarin, D. et al. Genetics of blood lipids among ~300,000 multi-ethnic participants of the Million Veteran Program. Nat. Genet. 50, 1514\u20131523 (2018).","journal-title":"Nat. Genet."},{"key":"2613_CR64","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1161\/CIRCULATIONAHA.122.059162","volume":"146","author":"SL Clarke","year":"2022","unstructured":"Clarke, S. L. et al. Race and ethnicity stratification for polygenic risk score analyses may mask disparities in Hispanics. Circulation 146, 265\u2013267 (2022).","journal-title":"Circulation"},{"key":"2613_CR65","doi-asserted-by":"crossref","DOI":"10.1186\/s13742-015-0047-8","volume":"4","author":"CC Chang","year":"2015","unstructured":"Chang, C. C. et al. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience 4, 7 (2015).","journal-title":"Gigascience"},{"key":"2613_CR66","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/nbt.4235","volume":"36","author":"R Poplin","year":"2018","unstructured":"Poplin, R. et al. A universal SNP and small-indel variant caller using deep neural networks. Nat. Biotechnol. 36, 983\u2013987 (2018).","journal-title":"Nat. Biotechnol."},{"key":"2613_CR67","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1093\/bioinformatics\/btu356","volume":"30","author":"H Li","year":"2014","unstructured":"Li, H. Toward better understanding of artifacts in variant calling from high-coverage samples. Bioinformatics 30, 2843\u20132851 (2014).","journal-title":"Bioinformatics"},{"key":"2613_CR68","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.ajhg.2019.08.012","volume":"105","author":"H Fang","year":"2019","unstructured":"Fang, H. et al. Harmonizing genetic ancestry and self-identified race\/ethnicity in genome-wide association studies. Am. J. Hum. Genet. 105, 763\u2013772 (2019).","journal-title":"Am. J. Hum. Genet."},{"key":"2613_CR69","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/s41588-021-00870-7","volume":"53","author":"J Mbatchou","year":"2021","unstructured":"Mbatchou, J. et al. Computationally efficient whole-genome regression for quantitative and binary traits. Nat. Genet. 53, 1097\u20131103 (2021).","journal-title":"Nat. Genet."},{"key":"2613_CR70","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-11-288","volume":"11","author":"R M\u00e4gi","year":"2010","unstructured":"M\u00e4gi, R. & Morris, A. P. GWAMA: software for genome-wide association meta-analysis. BMC Bioinformatics 11, 288 (2010).","journal-title":"BMC Bioinformatics"},{"key":"2613_CR71","doi-asserted-by":"crossref","first-page":"D998","DOI":"10.1093\/nar\/gkae1070","volume":"53","author":"M Cerezo","year":"2025","unstructured":"Cerezo, M. et al. The NHGRI-EBI GWAS Catalog: standards for reusability, sustainability and diversity. Nucleic Acids Res. 53, D998\u2013D1005 (2025).","journal-title":"Nucleic Acids Res."},{"key":"2613_CR72","doi-asserted-by":"crossref","first-page":"D766","DOI":"10.1093\/nar\/gky955","volume":"47","author":"A Frankish","year":"2019","unstructured":"Frankish, A. et al. GENCODE reference annotation for the human and mouse genomes. Nucleic Acids Res. 47, D766\u2013D773 (2019).","journal-title":"Nucleic Acids Res."},{"key":"2613_CR73","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41588-021-01011-w","volume":"54","author":"SJ Jurgens","year":"2022","unstructured":"Jurgens, S. J. et al. Analysis of rare genetic variation underlying cardiometabolic diseases and traits among 200,000 individuals in the UK Biobank. Nat. Genet. 54, 240\u2013250 (2022).","journal-title":"Nat. Genet."},{"key":"2613_CR74","volume":"1","author":"Z Xie","year":"2021","unstructured":"Xie, Z. et al. Gene set knowledge discovery with Enrichr. Curr. Protoc. 1, e90 (2021).","journal-title":"Curr. Protoc."},{"key":"2613_CR75","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1038\/ng.3977","volume":"49","author":"DJ Liu","year":"2017","unstructured":"Liu, D. J. et al. Exome-wide association study of plasma lipids in >300,000 individuals. Nat. Genet. 49, 1758\u20131766 (2017).","journal-title":"Nat. Genet."},{"key":"2613_CR76","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna, A. et al. The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297\u20131303 (2010).","journal-title":"Genome Res."},{"key":"2613_CR77","doi-asserted-by":"publisher","unstructured":"Koyama, S. The supplemental data and codes for Koyama et al. \u201cThe expressivity of rare coding variants for blood lipids in over a million individuals.\u201d Zendo https:\/\/doi.org\/10.5281\/zenodo.11092802 (2024).","DOI":"10.5281\/zenodo.11092802"}],"container-title":["Nature Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41588-026-02613-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41588-026-02613-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41588-026-02613-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T13:40:40Z","timestamp":1781271640000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41588-026-02613-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":77,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["2613"],"URL":"https:\/\/doi.org\/10.1038\/s41588-026-02613-y","relation":{},"ISSN":["1061-4036","1546-1718"],"issn-type":[{"value":"1061-4036","type":"print"},{"value":"1546-1718","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"assertion":[{"value":"17 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.K. is a scientific advisor and reports consulting fees from Bitterroot Bio unrelated to the present work. P.T.E. receives sponsored research support from Bayer AG, Bristol Myers Squibb, Pfizer and Novo Nordisk; he has also served on advisory boards or consulted for Bayer AG. P.N. reports research grants from Allelica, Amgen, Apple, Boston Scientific, Cleerly, Genentech\/Roche, Ionis, Novartis and Silence Therapeutics; personal fees from AIRNA, Allelica, Apple, AstraZeneca, Bain Capital, Blackstone Life Sciences, Bristol Myers Squibb, Creative Education Concepts, CRISPR Therapeutics, Eli Lilly, Esperion Therapeutics, Foresite Capital, Foresite Labs, Genentech\/Roche, GV, HeartFlow, Incyte, Magnet Biomedicine, Merck, Novartis, Novo Nordisk, TenSixteen Bio and Tourmaline Bio; equity in Bolt, Candela, Mercury, MyOme, Parameter Health, Preciseli and TenSixteen Bio; royalties from Recora for intensive cardiac rehabilitation; and spousal employment at Vertex Pharmaceuticals, all unrelated to the present work. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}